Athena Diagnostics filed its petition for certiorari with the U.S. Supreme Court yesterday in Athena Diagnostics v. Mayo Collaborative Services. There is a strong argument for the Court to grant the petition, and patent stakeholders on all sides are sure to weigh in via amicus briefs over the next month. The petition could represent the best chance for clarifying Section 101 law in the near-term, since patent reform efforts on the topic have been seemingly stalled. Below are a few initial reactions from the patent community to Athena’s arguments.
Will the Supreme Court Solve the Section 101 Problem with Athena? These Patent Attorneys Hope So
No Comments
Business
- Examining Samsung’s and LG’s LCD Patent Portfolios Following Decisions to Halt LCD Production
- DOJ Takes Key Step Toward Breaking Up Big Tech with Antitrust Complaint Against Google
- 3D Printing: Adoptability, Assurance, IP and Consumer Concerns
- Don’t Let the Pandemic End Your Startup: Tips for Shoring Up Agreements Among Business Partners
- Eagle Forum Event Focuses on IP, Antitrust Nexus
Recent Posts
- This Week in Washington IP: Senate Commerce Committee to Grill Tech CEOs on Section 230, House Big Tech Antitrust Report and USPTO’s Quarterly TPAC Meeting
- Determining the Likelihood that an AI Patent Application Will Be Allowed at the USPTO
- Examining Samsung’s and LG’s LCD Patent Portfolios Following Decisions to Halt LCD Production
- Types of Subsequent Patent Applications in the United States (Part II)
- Will SCOTUS Tell Bad Spaniels to Roll Over?